Nisin

Nisin is the prototypical lantibiotic (lanthionine-containing antibiotic), a class of ribosomally synthesized and post-translationally modified peptides produced by certain lactic acid bacteria. Its unique structure includes thioether bridges (lanthionine and methyllanthionine) and dehydrated amino acids that create a constrained topology essential for biological activity.

The peptide exhibits potent activity against gram-positive bacteria through a dual mechanism: it binds to Lipid II (the essential peptidoglycan precursor) and uses this interaction to form pores in the bacterial membrane. This dual action makes resistance development extremely difficult, as Lipid II is an essential and highly conserved target.

Nisin has GRAS (Generally Recognized as Safe) status and is widely used as a natural food preservative, particularly in dairy products and canned foods. It represents one of the most successful applications of antimicrobial peptides in commerce, with decades of safe use history.

Research interest extends to medical applications including treatment of antibiotic-resistant gram-positive infections (MRSA, VRE), biofilm-associated infections, and as a model for developing novel lantibiotic-based therapeutics. The growing antibiotic resistance crisis has renewed interest in lantibiotics as a source of new antimicrobial agents with unique mechanisms of action.